Literature DB >> 18509014

Rapid determination of monozygous twinning with a microfabricated capillary array electrophoresis genetic-analysis device.

Stephanie H I Yeung1, Igor L Medintz, Susan A Greenspoon, Richard A Mathies.   

Abstract

BACKGROUND: Microfabricated genetic-analysis devices have great potential for delivering complex clinical diagnostic technology to the point of care. As a demonstration of the potential of these devices, we used a microfabricated capillary array electrophoresis (microCAE) instrument to rapidly characterize the familial and genotypic relationship of twins who had been assigned fraternal (dizygous) status at birth.
METHODS: We extracted the genomic DNA from buccal samples collected from the twin sons, the parents, another sibling, and an unrelated control individual. We then carried out multiplex PCR amplification of sequences at 16 short tandem repeat loci commonly used in forensic identity testing. We simultaneously separated the amplicons from all of the individuals on a microCAE device and fluorescently detected the amplicons with single-base resolution in <30 min.
RESULTS: The genotypic analysis confirmed the identical status of the twins and revealed, in conjunction with the medical data, that their twin status arose from the rarer dichorionic, diamniotic process.
CONCLUSIONS: The ability to rapidly analyze complex genetic samples with microCAE devices demonstrates that this approach can help meet the growing need for rapid genetics-based diagnostics.

Mesh:

Year:  2008        PMID: 18509014     DOI: 10.1373/clinchem.2007.102319

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

Review 1.  Towards non- and minimally instrumented, microfluidics-based diagnostic devices.

Authors:  Bernhard Weigl; Gonzalo Domingo; Paul Labarre; Jay Gerlach
Journal:  Lab Chip       Date:  2008-10-29       Impact factor: 6.799

Review 2.  Miniaturized technology for protein and nucleic acid point-of-care testing.

Authors:  Felix Olasagasti; Juan Carlos Ruiz de Gordoa
Journal:  Transl Res       Date:  2012-03-11       Impact factor: 7.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.